Clinical Trials Logo

Pleural Effusion clinical trials

View clinical trials related to Pleural Effusion.

Filter by:

NCT ID: NCT00465907 Terminated - Lung Cancer Clinical Trials

Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer

Start date: May 2003
Phase: Phase 2
Study type: Interventional

Evaluate the efficacy and toxicity of the weekly combination chemotherapy of Paclitaxel, Carboplatin and Irinotecan in Stage IIIb and IV NSCLC with malignant pleural effusion

NCT ID: NCT00402896 Terminated - Lung Cancer Clinical Trials

Malignant Pleural Effusion With ZD6474

Start date: October 2006
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn the effect of ZD6474 on the amount of time between placement of an indwelling pleural catheter and the catheter's removal in patients with malignant pleural effusion. This study will also look at the effect that ZD6474 has on tumor cells, biological characteristics of cells in the body, rate of fluid build-up around the lungs, tumor size, and thickness of blood vessels. The effect that this drug has on quality of life and shortness of breath will also be examined.

NCT ID: NCT00316134 Terminated - Pleural Effusion Clinical Trials

Multiple Biomarkers in Undiagnosed Pleural Effusion

Start date: March 2006
Phase: N/A
Study type: Observational

The purpose of this clinical trial is to evaluate the ability of various biomarkers measured in serum and/or pleural fluids to estimate the risk of finding cancer in patients with undiagnosed pleural effusions. An algorithm for prediction of the risk of finding cancer in the patient using an optimal combination of markers will be developed, and patients will be categorized as having a low, moderate, or high risk of finding cancer that might be used to more effectively triage patients.